The FDA Approves Tzield, the Only Drug That Delays Type 1 Diabetes
Fantastic news: Last week, the US FDA officially approved teplizumab-mzwv (Tzield), the only drug that has been demonstrated to delay the onset of type 1 diabetes. Diabetes Daily has been eagerly following Tzield for years, and last year, we supported a letter-writing campaign to the FDA in the new drug’s support. “Tzield” is the new … Read more